EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Evaluation of QuickMIC system for rapid antimicrobial susceptibility testing of Gram-negative pathogens from positive blood cultures, including strains producing extended-spectrum β-lactamases and carbapenemases

Fabio Morecchiato, Chiara Chilleri, Alberto Antonelli iD, Christer Malmberg, Tommaso Giani iD, Gian Maria Rossolini iD

Microbiology Spectrum · 2025-07 · 13 (7)

DOI: 10.1128/spectrum.00370-25 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Microbiology Spectrum, 2025-07. Verfasst von Fabio Morecchiato und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, University of Florence, Florence, Tuscany, Italy. Hauptthemen laut MEDLINE: beta-Lactamases, Anti-Bacterial Agents, Gram-Negative Bacteria, Bacterial Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The accuracy and turnaround time (TAT) of the QuickMIC system (QMIC) for rapid antimicrobial susceptibility testing (AST) of Gram-negative pathogens from positive blood cultures were evaluated, in comparison with a standard-of-care workflow based on culture and AST with broth microdilution. Essential agreement (EA) and bias were evaluated according to the ISO 20776-2:2021, category agreement (CA), categorical overestimation (CO), and underestimation (CU) rates were evaluated according to the European Committee on Antimicrobial Susceptibility Testing(EUCAST) breakpoints, and major discrepancy (MD) and very major discrepancy (VMD) rates were evaluated according to the Food and Drug Administration (FDA) guidelines and breakpoints. QMIC yielded evaluable data for 103/118 blood cultures (87.3%), including Enterobacterales ( N = 82), Pseudomonas aeruginosa ( N = 16), and Acinetobacter baumannii complex ( N = 5). Overall, 41 isolates (39.8%) were positive for extended-spectrum β-lactamases and/or carbapenemases. QMIC exhibited EA and CA values of 89.5% and 93.3%, respectively, with values ±30% observed with colistin and piperacillin-tazobactam. Overall, CO and CU were observed in 2.3% and 4.4% of cases. MD and VMD with FDA breakpoints were observed in 1.5% and 8.9% of cases, respectively. The lowest accuracy of QMIC in terms of CU was observed with cefepime, colistin, and gentamicin and in terms of VMD with ceftazidime-avibactam, meropenem, and piperacillin-tazobactam. The mean TAT for QMIC was 192 ± 18 min. QMIC demonstrated the potential for rapid AST, with a mean time to result of less than 4 hours, and an overall acceptable accuracy, except with some β-lactams. Further studies are warranted to assess the potential impact of QMIC implementation on clinical outcomes. IMPORTANCE The introduction of rapid antimicrobial susceptibility testing (AST) systems for positive blood cultures (BCs) is one of the most promising technological advancements to improve bloodstream infections diagnosis, by providing faster results useful for antimicrobial stewardship. The value of such systems is expected to be higher in settings of high endemicity of antimicrobial resistance, where phenotype prediction is more difficult, and rates of inaccurate empirical therapies are expected to be higher. In this study, we investigated the accuracy and turnaround time (TAT) of a new rapid AST system for positive BCs, in comparison with a standard-of-care workflow based on broth microdilution, including several cases positive for extended-spectrum β-lactamase- and/or carbapenemase-producing Gram negatives. TAT was 192 ± 18 min, and a good accuracy was observed for testing some agents (amikacin, gentamicin, ciprofloxacin, colistin, and ceftazidime-avibactam) but a lower accuracy for testing other agents (cefepime, meropenem, and piperacillin-tazobactam). Further assessment of this technology, after improving accuracy, is warranted to evaluate the clinical impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesAnti-Bacterial AgentsGram-Negative BacteriaBacterial ProteinsGram-Negative Bacterial InfectionsHumansMicrobial Sensitivity TestsBlood CultureBacteremiaAcinetobacter baumanniiPseudomonas aeruginosa

Stichwörter der Autor:innen

antimicrobial susceptibility testingblood culturesbloodstream infectionsdiagnosisrapid phenotypic antibiogram

Substanzen

beta-LactamasesAnti-Bacterial AgentscarbapenemaseBacterial Proteins

Autor:innen und Institutionen

  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Tuscany, Italy.
  • Microbiology and Virology Unit, Careggi University Hospital, Florence, Tuscany, Italy.
  • Gradientech AB - Uppsala (Sweden), Uppsala, Uppsala County, Sweden.
  • Department of Medical Sciences, Uppsala University - Uppsala (Sweden), Uppsala, Uppsala County, Sweden.

ORCID-Profile: Alberto Antonelli, Tommaso Giani, Gian Maria Rossolini

Förderung

  • Italian Ministry of Health

Zitieren

APA

Morecchiato, F., Chilleri, C., Antonelli, A., Malmberg, C., Giani, T., & Rossolini, G. M. (2025). Evaluation of QuickMIC system for rapid antimicrobial susceptibility testing of Gram-negative pathogens from positive blood cultures, including strains producing extended-spectrum β-lactamases and carbapenemases. Microbiology Spectrum, 13(7). https://doi.org/10.1128/spectrum.00370-25

Vancouver

Morecchiato F, Chilleri C, Antonelli A, Malmberg C, Giani T, Rossolini GM. Evaluation of QuickMIC system for rapid antimicrobial susceptibility testing of Gram-negative pathogens from positive blood cultures, including strains producing extended-spectrum β-lactamases and carbapenemases. Microbiology Spectrum. 2025;13(7). doi:10.1128/spectrum.00370-25

BibTeX
@article{Morecchiato2025,
  author = {Morecchiato, Fabio and Chilleri, Chiara and Antonelli, Alberto and Malmberg, Christer and Giani, Tommaso and Rossolini, Gian Maria},
  title = {Evaluation of QuickMIC system for rapid antimicrobial susceptibility testing of Gram-negative pathogens from positive blood cultures, including strains producing extended-spectrum β-lactamases and carbapenemases},
  journal = {Microbiology Spectrum},
  year = {2025},
  volume = {13},
  number = {7},
  doi = {10.1128/spectrum.00370-25}
}
Kostenlos starten →